Company intelligence / Profile preview

Burrill

San Francisco, California, USA

Ownership: Private
Development stage: Other

Overview

Burrill & Company was a prominent San Francisco-based venture capital and investment banking firm focused exclusively on the life sciences industry. Founded by G. Steven Burrill in 1994, the firm managed numerous funds and provided strategic advisory services to biotech, pharmaceutical, and medical device companies. At its peak, it was a leading voice in the industry, known for publishing the annual "Burrill Report" on the state of biotechnology. The firm's investment portfolio included a wide array of companies across healthcare, ag-bio, and industrial biotechnology. However, the firm collapsed following allegations of financial misconduct and the misappropriation of investor funds by its founder. In 2016, the SEC reached a settlement with G. Steven Burrill regarding these charges, effectively ending the firm's operations.

Industry: Investors

Beyond the preview

Go deeper on Burrill.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Burrill.

Explore the full profile